C-reactive protein and immunoglobulin-E response to coronary artery stenting in patients with stable angina

Japanese Heart Journal

Volumn 44, Issue 5, 2003, Pages 593-600

  Erdogan, Okan ^a,b   Altun, Armagan ^a   Gul, Cetin ^a   Ozbay, Gultac ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Atherosclerosis; C reactive protein; Immunoglobulin E; Inflammation; Stent

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; IMMUNOGLOBULIN E;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY STENT; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MALE; PATHOGENESIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTENOSIS; STABLE ANGINA PECTORIS; TIME;

AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STENTS;

EID: 10644227190     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.44.593     Document Type: Article

References (23)

1. Fischman DL, Leon ML, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Eng J Med 1994; 331: 496-501.
2. Serruys P, de Jaegere P, Kiemeniej F, et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Eng J Med 1994; 331: 489-95.
3. De Servi S, Mazzone A, Ricevuti G, et al. Granulocyte activation after coronary angioplasty in humans. Circulation 1990; 82: 140-6.
4. Pietersma A, Kofflard M, de Wit EA, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995; 91: 1320-5.
5. Pepys MB. C-reactive protein fifty years on. Lancet 1981; 1: 653-6.
6. Forman MB, Oates JA, Robertson D, et al. Increased adventitial mast cells in a patient with coronary spasm. N Eng J Med 1985; 313: 1138.
7. Pomerance A. Peri-arterial mast cells in coronary atheroma and thrombosis. J Pathol Bacteriol 1958; 76: 55.
8. Ishizaka T, Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy 1984; 34: 188-235.
9. Merrett J, Merrett TG. Screening for IgE-mediated allergy. J Clin Immunoassay 1993; 16: 164-72.
10. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment on Diagnostic and Therapeutic Cardiovascular Procedures. Circulation 1988; 78: 486-502.
11. Libby PS, Warmer JC, Friedman GB, et al. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth inhibitory prostanoids. J Clin Invest 1988; 81: 487-98.
12. Van der Wal AC, Becker AE, Koch KT. Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques. Heart 1996; 76: 312-6.
13. Kuller LH, Tracy RP, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case control study. Multiple risk factor intervention trial. Am J Epidemiol 1996; 144: 537-47.
14. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Eng J Med 1997; 336: 973-9.
15. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995; 92: 1084-8.
16. Irani AA, Schechter NM, Craig SS, et al. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83: 4464-8.
17. Sedgwick JD, Holt PG, Turner KJ. Production of a histamine-releasing lymphokine by antigen or mitogen stimulated human peripheral T cells. Clin Exp Immunol 1981; 45: 409-18.
18. Liu MC, Proud D, Lichtenstein LM. Human lung macrophage derived histamine releasing activity is due to IgE dependent factors. J Immunol 1986; 136: 2588-95.
19. Erdogan O, Gul C, Altun A, Ozbay G. Increased IgE response in acute coronary syndromes. Angiology (in press)
20. Busse WW, Lemanske RF. Advances in immunology: Asthma. N Eng J Med 2001; 344: 350-62.
21. Szczeklik A, Sladek K, Szczerba A, et al. Serum immunoglobulin E response to myocardial infarction. Circulation 1988; 77: 1245-9.
22. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, et al. Plasma levels of C-reactive protein after coronary artery stent implantation. Eur Heart J 2000; 21: 1152-8.
23. Gaspardone A, Crea F, Versaci F, et al. Predictive value of C-reactive protein after successful coronary artery stenting in patients with stable angina. Am J Cardiol 1998; 82: 515-8.